A phase II study of concurrent WOKVAC vaccination with neoadjuvant chemotherapy and HER2-targeted monoclonal antibody therapy.

Abstract

TPS636

Document Details

Document Type
Pub Defense Publication
Publication Date
Jun 01, 2023
Source ID
10.1200/jco.2023.41.16_suppl.tps636

Entities

People

  • Andrew L. Coveler
  • Jennifer Childs
  • John B Liao
  • Kristin Kuano
  • Lynn Katherine Symonds
  • Mary L. Disis
  • Shaveta Vinayak
  • William R. Gwin

Organizations

  • United States Department of Defense
  • University of Washington

Tags

Technology Areas

  • Biotechnology
  • Biotechnology - Cancer Biotech